Comparison of Genomic Abnormalities and Gene Expression Analysis in Atypical, Ambiguous and Malignant Melanocytic Lesions

被引：0
|
作者：
Wang, Grace [1 ]
Wang, Min [1 ]
Alomari, Ahmed [1 ]
Andea, Aleodor [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
537
引用
收藏
页码：137A / 137A
页数：1
相关论文
共 50 条
  • [41] INTERLEUKIN-2 RECEPTOR EXPRESSION IN BENIGN AND MALIGNANT MELANOCYTIC SKIN-LESIONS
    KERNOHAN, NM
    SEWELL, HF
    JOURNAL OF PATHOLOGY, 1989, 157 (04): : 315 - 319
  • [42] p16ink4a Expression in Benign and Malignant Melanocytic Conjunctival Lesions
    Zoroquiain, Pablo
    Fernandes, Bruno F.
    Gonzalez, Sergio
    Novais, Gustavo N.
    Schalper, Kurt A.
    Burnier, Miguel N., Jr.
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2012, 20 (03) : 240 - 245
  • [43] Immunohistochemical Analysis with a Novel Red Chromagen of Benign and Malignant Melanocytic Lesions of the Conjunctiva
    Brownstein, Seymour
    Jiang, Kailun
    Lam, Kay
    Burns, Bruce
    Farmer, James
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [44] Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic Lesions
    Zaremba, Anne
    Jansen, Philipp
    Murali, Rajmohan
    Mayakonda, Anand
    Riedel, Anna
    Krahl, Dieter
    Burkhardt, Hans
    John, Stefan
    Geraud, Cyrill
    Philip, Manuel
    Kretz, Julia
    Moeller, Inga
    Stadtler, Nadine
    Sucker, Antje
    Paschen, Annette
    Ugurel, Selma
    Zimmer, Lisa
    Livingstone, Elisabeth
    Horn, Susanne
    Plass, Christoph
    Schadendorf, Dirk
    Hadaschik, Eva
    Lutsik, Pavlo
    Griewank, Klaus
    CANCERS, 2022, 14 (17)
  • [45] Expression of the PRAME immunohistochemical marker in melanocytic lesions: a potential biomarker and its role in differential diagnosis of malignant lesions
    Mod, B. Noyan
    Leblebici, C.
    VIRCHOWS ARCHIV, 2024, 485 : S36 - S37
  • [46] Follow-up atypical melanocytic lesions with Dermato fluoroscopy: rapid malignant degeneration, stable state or repair
    Scholz, M.
    Leupold, D.
    Szyc, L.
    Stankovic, G.
    Pfeifer, L.
    Buder, S.
    Giering, H. -G.
    MELANOMA RESEARCH, 2016, 26 : E49 - E49
  • [47] Correlation of melanoma gene expression score with clinical outcomes on a series of melanocytic lesions
    Ko, Jennifer S.
    Clarke, Loren E.
    Minca, Eugen C.
    Brown, Krystal
    Flake, Dart D., II
    Billings, Steven D.
    HUMAN PATHOLOGY, 2019, 86 : 213 - 221
  • [48] The influence of a gene-expression signature on the treatment of diagnostically challenging melanocytic lesions
    Cockerell, Clay
    Tschen, Jaime
    Billings, Steven D.
    Evans, Brent
    Brown, Krystal
    Rock, Colleen
    Clarke, Loren E.
    PERSONALIZED MEDICINE, 2017, 14 (02) : 123 - 130
  • [49] H2A.X phosphorylation in melanocytic lesions: Expression in malignant melanoma and melanocytic nevi with severe architectural and cytologic atypia
    Cheung, W. L.
    Moresi, J. M.
    Netto, G. J.
    LABORATORY INVESTIGATION, 2008, 88 : 92A - 92A
  • [50] H2A.X phosphorylation in melanocytic lesions: Expression in malignant melanoma and melanocytic nevi with severe architectural and cytologic atypia
    Cheung, W. L.
    Moresi, J. M.
    Netto, G. J.
    MODERN PATHOLOGY, 2008, 21 : 92A - 92A
12345